{"gene":"TG_222170","gene_symbol":"GRA17","run_date":"2026-09-08T11:06:39","timeline":{"discoveries":[{"year":2015,"finding":"GRA17 is a Toxoplasma-secreted dense granule protein that localizes to the parasitophorous vacuole membrane (PVM) and mediates passive transport of small molecules across the PVM, functioning as a large non-selective pore. GRA17-deficient parasites exhibit aberrant PV morphology, reduced PVM permeability, structural instability, slow proliferation, and avirulence in mice. GRA17 functions synergistically with GRA23, and exogenous expression of GRA17 in Xenopus oocytes alters membrane conductance consistent with a large non-selective pore.","method":"Genetic knockout, PV permeability assays, complementation with Plasmodium EXP2, Xenopus oocyte electrophysiology, localization by fluorescence microscopy","journal":"Cell host & microbe","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (KO phenotype, electrophysiology, cross-species complementation, permeability assays, localization), replicated in subsequent studies","pmids":["25974303"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2015,"finding":"GRA17 is functionally related to the Plasmodium EXP2 translocon protein and is conserved across PV-residing Apicomplexa. Complementation of GRA17-deficient Toxoplasma parasites with Plasmodium EXP2 rescues the GRA17-deficient phenotypes (PV morphology, permeability, growth), establishing functional conservation between these pore-forming proteins.","method":"Heterologous complementation of Toxoplasma GRA17 knockout with Plasmodium EXP2, PV morphology and permeability assays","journal":"Cell host & microbe","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean complementation experiment with functional readouts, replicated in follow-up studies","pmids":["25974303"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2019,"finding":"GRA17 plays an important role in bradyzoite viability inside cysts. Deletion of GRA17 in the type II ME49 strain produced enlarged 'bubble vacuoles' with reduced PVM permeability. ME49Δgra17 parasites formed cysts in vitro at comparable rates to wild-type, but bradyzoite viability inside cysts was significantly reduced. Complementation with GRA17 expressed from a bradyzoite-specific promoter (SRS9) drastically increased bradyzoite viability, demonstrating GRA17's importance in the cyst stage.","method":"CRISPR-Cas9 knockout in ME49 strain, cyst formation assays, bradyzoite viability assays, genetic complementation with stage-specific promoters, PVM permeability assays","journal":"Frontiers in cellular and infection microbiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype, multiple complementation constructs, orthogonal readouts in single lab","pmids":["31572690"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"}]},{"year":2020,"finding":"Deletion of gra17 in Toxoplasma gondii type II Pru strain abrogated acute infection and blocked cyst formation, demonstrating GRA17's role in establishing chronic infection. Pru:Δgra17 mutants developed PVs with abnormal morphology and exhibited a reduced growth rate compared to wild-type.","method":"CRISPR-Cas9 knockout, mouse infection model, PV morphology analysis, growth rate measurement","journal":"Parasitology research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined phenotypic readouts, consistent with prior findings in RH and ME49, single lab","pmids":["32686022"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2023,"finding":"In vivo CRISPR screen results suggest a role of GRA72 for normal GRA17/GRA23 localization, indicating that GRA72 is required upstream of GRA17 for its proper targeting to the PVM.","method":"In vivo CRISPR screen in C57BL/6 and Ifngr1-/- mice","journal":"Cell reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — screen result suggesting localization dependence, single method, no direct mechanistic follow-up in this paper","pmids":["37269286"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2024,"finding":"GRA47 interacts with GRA72 (identified by immunoprecipitation), and both GRA47 and GRA72 are pore-forming proteins that regulate PVM permeability alongside GRA17. Overexpression of GRA17 (or GRA23 or GRA72) partially rescued aberrant PV morphology in Δgra47 parasites, and P. falciparum PfExp2 (an ortholog of GRA17/GRA23) fully rescued PV morphological defects in Δgra47, Δgra72, and Δgra17 strains, indicating partial functional redundancy among this family of pore-forming GRA proteins.","method":"Co-immunoprecipitation, gene deletion (CRISPR), PV morphology assays, overexpression complementation with GRA17/GRA23/GRA72 and PfExp2, electrophysiology (Xenopus oocytes)","journal":"mBio","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal IP, multiple KO strains, cross-species complementation, electrophysiology; published in peer-reviewed journal after preprint","pmids":["38380952"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2024,"finding":"Co-immunoprecipitation demonstrated interaction of GRA47 with GRA72. Loss of GRA72 affected PV morphology, parasite growth, and infectivity. Overexpressing GRA17 partially rescued PVs with aberrant morphology in Δgra47 and Δgra72 parasites, while PfExp2 fully rescued the PV morphological defect in Δgra17, Δgra47, and Δgra72 strains.","method":"Co-immunoprecipitation, CRISPR knockout, overexpression complementation, PV morphology assays","journal":"International journal for parasitology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and functional complementation, single lab, consistent with parallel study in mBio","pmids":["38936501"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2025,"finding":"GRA1 inactivation impaired the secretion of GRA17 to the PVM and disrupted the intravacuolar network (IVN), which mediates transport of molecules in and out of parasites. Mislocalization of GRA17 (and other GRA proteins) caused by GRA1 depletion resulted in a strong defect in absorbing nutrients (glucose, pantothenate) from host cells, placing GRA1 upstream of GRA17 in the nutrient uptake pathway.","method":"Conditional depletion of GRA1, fluorescence localization of GRA17, nutrient uptake assays, metabolic assays","journal":"mBio","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined localization and functional readouts, but GRA17 localization is a secondary finding in a paper focused on GRA1","pmids":["40576341"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2025,"finding":"AAP7 (apical annuli protein 7) is required for efficient secretion of GRA17 from dense granules. AAP7 depletion causes reduced GRA17 secretion, leading to 'bubble' vacuoles characteristic of GRA17 loss. Overexpression of GRA17 overcomes AAP7 depletion and reduces bubble vacuoles, identifying reduced GRA17 secretion as the critical defect downstream of AAP7 loss.","method":"Conditional depletion (ATc-resistant stable line), GRA17 overexpression rescue, fluorescence microscopy of PV morphology","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — depletion with defined phenotype, rescue by GRA17 overexpression, but preprint and single lab","pmids":["41256620"],"is_preprint":true,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2026,"finding":"Genetic ablation of TgGRA17 compromises the growth advantage conferred by elevated exogenous lactate, implicating GRA17 pore as the entry route for host-derived monocarboxylates (lactate, pyruvate) into the parasitophorous vacuole.","method":"Genetic knockout of GRA17 combined with hexokinase knockout, growth assays with elevated exogenous lactate","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined metabolic phenotype and specific substrate (monocarboxylates), but preprint and single lab","pmids":["42124602"],"is_preprint":true,"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"current_model":"GRA17 is a Toxoplasma gondii dense granule protein that localizes to the parasitophorous vacuole membrane (PVM) and forms a large, non-selective passive pore (related to Plasmodium EXP2) that mediates small molecule permeability—including nutrient (glucose, monocarboxylates, pantothenate) uptake and metabolite efflux—across the PVM; its proper secretion to the PVM requires the intravacuolar network scaffold GRA1 and the apical annuli protein AAP7, it functions synergistically with the related pore-forming protein GRA23 (and partially with GRA47/GRA72), and its loss causes aberrant 'bubble vacuole' morphology, reduced PVM permeability, impaired tachyzoite proliferation, reduced bradyzoite viability in cysts, and parasite avirulence in mice."},"narrative":{"mechanistic_narrative":"GRA17 is a Toxoplasma gondii dense granule protein that localizes to the parasitophorous vacuole membrane (PVM), where it forms a large non-selective pore mediating passive transport of small molecules across the PVM [PMID:25974303]. This pore activity is functionally conserved with the Plasmodium EXP2 translocon, which fully complements GRA17-deficient parasites for PVM permeability, PV morphology, and growth [PMID:25974303]. GRA17 operates within a redundant family of pore-forming GRA proteins, acting synergistically with GRA23 and partially interchangeably with GRA47 and GRA72, whose overexpression partially rescues aberrant PV morphology in reciprocal deletion mutants [PMID:25974303, PMID:38380952]. Functionally, the GRA17 pore serves as an entry route for host-derived nutrients including glucose, pantothenate, and monocarboxylates such as lactate and pyruvate into the vacuole [PMID:40576341, PMID:42124602]. Proper delivery of GRA17 to the PVM depends on the intravacuolar network scaffold GRA1 and on the apical annuli protein AAP7, both of which act upstream of GRA17 secretion [PMID:40576341, PMID:41256620]. Loss of GRA17 produces enlarged 'bubble' vacuoles with reduced PVM permeability, structural instability, slow proliferation, avirulence in mice, and impaired chronic infection—including reduced bradyzoite viability within cysts and blocked cyst formation [PMID:25974303, PMID:31572690, PMID:32686022].","teleology":[{"year":2015,"claim":"Established that GRA17 is the molecular basis of passive small-molecule permeability across the PVM, answering how the intracellular parasite exchanges solutes with the host cytosol.","evidence":"Genetic knockout with PVM permeability assays, Xenopus oocyte electrophysiology, and cross-species complementation with Plasmodium EXP2 in RH strain","pmids":["25974303"],"confidence":"High","gaps":["Pore selectivity and structural architecture not resolved","Full spectrum of transported solutes not defined","Mechanism of synergy with GRA23 not characterized"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2015,"claim":"Demonstrated that GRA17 pore function is evolutionarily conserved across PV-residing Apicomplexa by showing Plasmodium EXP2 fully rescues GRA17 loss, unifying these pore-forming proteins mechanistically.","evidence":"Heterologous complementation of Toxoplasma GRA17 knockout with Plasmodium EXP2 and functional readouts in RH strain","pmids":["25974303"],"confidence":"High","gaps":["Structural equivalence of the two pores not established","Whether native cofactors differ between species unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2019,"claim":"Extended GRA17's role beyond acute infection by showing it is required for bradyzoite viability within cysts, linking PVM permeability to persistence of the chronic stage.","evidence":"CRISPR-Cas9 knockout in ME49 strain with cyst formation and bradyzoite viability assays and stage-specific promoter complementation","pmids":["31572690"],"confidence":"High","gaps":["Specific metabolic requirement of bradyzoites met by GRA17 not identified","Whether cyst wall permeability compensates in vivo unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"}]},{"year":2020,"claim":"Confirmed GRA17's requirement for establishing chronic infection by showing deletion abrogates acute infection and blocks cyst formation in a type II strain.","evidence":"CRISPR-Cas9 knockout with mouse infection model and PV morphology analysis in Pru strain","pmids":["32686022"],"confidence":"Medium","gaps":["Molecular cause of block in cyst formation not defined","Contribution of host immune context not dissected"],"attribution":[{"species":"Toxoplasma gondii","strain":"Pru"}]},{"year":2024,"claim":"Defined a redundant family of pore-forming GRA proteins by showing GRA47/GRA72 regulate PVM permeability alongside GRA17 and that cross-family and cross-species overexpression rescues morphological defects, clarifying functional interchangeability.","evidence":"Co-immunoprecipitation, multiple CRISPR knockouts, overexpression and PfExp2 complementation, and Xenopus oocyte electrophysiology in RH strain","pmids":["38380952","38936501"],"confidence":"High","gaps":["Whether these proteins form a shared complex or independent pores unresolved","Stoichiometry and assembly of the family not determined"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2025,"claim":"Placed GRA1 upstream of GRA17 by showing that GRA1 loss mislocalizes GRA17 and impairs nutrient (glucose, pantothenate) uptake, connecting IVN scaffolding to pore delivery.","evidence":"Conditional depletion of GRA1 with GRA17 localization, nutrient uptake and metabolic assays in RH strain","pmids":["40576341"],"confidence":"Medium","gaps":["Whether GRA1 directly traffics GRA17 or acts indirectly via IVN not distinguished","GRA17 localization was a secondary finding in a GRA1-focused study"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2025,"claim":"Identified AAP7 as a secretion factor for GRA17 by showing AAP7 depletion reduces GRA17 secretion and produces bubble vacuoles that GRA17 overexpression reverses, pinpointing GRA17 delivery as the critical downstream defect.","evidence":"Conditional depletion with GRA17 overexpression rescue and PV morphology microscopy in RH strain (preprint)","pmids":["41256620"],"confidence":"Medium","gaps":["Preprint, single lab","Mechanism by which apical annuli protein controls dense granule secretion unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2026,"claim":"Assigned monocarboxylates (lactate, pyruvate) as substrates transported by the GRA17 pore by showing GRA17 ablation removes the growth advantage of exogenous lactate, refining the nutrient-uptake role.","evidence":"GRA17 knockout combined with hexokinase knockout and growth assays under elevated exogenous lactate (preprint)","pmids":["42124602"],"confidence":"Medium","gaps":["Preprint, single lab","Direct transport measurement of monocarboxylates through GRA17 not shown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":null,"claim":"The structural architecture of the GRA17 pore, its selectivity determinants, and whether the GRA17/GRA23/GRA47/GRA72 family assembles into a shared translocon complex remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the pore","Assembly and stoichiometry of the pore-forming GRA family undefined","Direct biochemical demonstration of individual solute transport lacking"],"attribution":[]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":["GRA23","GRA47","GRA72","GRA1","AAP7"],"other_free_text":["Forms a large non-selective passive pore in the PVM functionally interchangeable with Plasmodium EXP2 [#0, #1, #5].","Loss produces enlarged 'bubble' vacuoles with reduced PVM permeability and structural instability [#0, #2, #8].","Required for tachyzoite proliferation, virulence in mice, and chronic infection including bradyzoite viability in cysts [#0, #2, #3].","Secretion to the PVM depends on GRA1 and AAP7 acting upstream [#7, #8]."]},"strain_conflicts":[]},"prefetch_data":{},"corpus_meta":[{"pmid":"25974303","id":"PMC_25974303","title":"The Toxoplasma Dense Granule Proteins GRA17 and GRA23 Mediate the Movement of Small Molecules between the Host and the Parasitophorous Vacuole.","date":"2015","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/25974303","citation_count":203,"is_preprint":false},{"pmid":"28706518","id":"PMC_28706518","title":"Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice.","date":"2017","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28706518","citation_count":55,"is_preprint":false},{"pmid":"37269286","id":"PMC_37269286","title":"Host genetics highlights IFN-γ-dependent Toxoplasma genes encoding secreted and non-secreted virulence factors in in vivo CRISPR screens.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37269286","citation_count":30,"is_preprint":false},{"pmid":"31572690","id":"PMC_31572690","title":"The GRA17 Parasitophorous Vacuole Membrane Permeability Pore Contributes to Bradyzoite Viability.","date":"2019","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31572690","citation_count":26,"is_preprint":false},{"pmid":"38380952","id":"PMC_38380952","title":"Two Toxoplasma gondii putative pore-forming proteins, GRA47 and GRA72, influence small molecule permeability of the parasitophorous vacuole.","date":"2024","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/38380952","citation_count":24,"is_preprint":false},{"pmid":"28625894","id":"PMC_28625894","title":"Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.","date":"2017","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/28625894","citation_count":20,"is_preprint":false},{"pmid":"32121619","id":"PMC_32121619","title":"RHΔgra17Δnpt1 Strain of Toxoplasma gondii Elicits Protective Immunity Against Acute, Chronic and Congenital Toxoplasmosis in Mice.","date":"2020","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/32121619","citation_count":18,"is_preprint":false},{"pmid":"32686022","id":"PMC_32686022","title":"Effect of deletion of gra17 and gra23 genes on the growth, virulence, and immunogenicity of type II Toxoplasma gondii.","date":"2020","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/32686022","citation_count":12,"is_preprint":false},{"pmid":"38936501","id":"PMC_38936501","title":"GRA47 is important for the morphology and permeability of the parasitophorous vacuole in Toxoplasma gondii.","date":"2024","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/38936501","citation_count":11,"is_preprint":false},{"pmid":"40576341","id":"PMC_40576341","title":"The critical role of Toxoplasma gondii GRA1 in nutrient salvage.","date":"2025","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/40576341","citation_count":3,"is_preprint":false},{"pmid":"40287105","id":"PMC_40287105","title":"Toxoplasma cyst wall CST9 elicits an acute-associated humoral response in humans and mice and protects against chronic infection in immunized mice.","date":"2025","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/40287105","citation_count":2,"is_preprint":false},{"pmid":"38014337","id":"PMC_38014337","title":"GRA47 and GRA72 are Toxoplasma gondii pore-forming proteins that influence small molecule permeability of the parasitophorous vacuole.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38014337","citation_count":1,"is_preprint":false},{"pmid":"41256620","id":"PMC_41256620","title":"Toxoplasma gondii AAP7 is essential for functionally connecting the IMC embedded apical annuli to the plasma membrane.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41256620","citation_count":0,"is_preprint":false},{"pmid":"42124602","id":"PMC_42124602","title":"A two-membrane gateway for monocarboxylates couples host glycolysis to Toxoplasma mitochondrial fitness and virulence.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/42124602","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10633,"output_tokens":3044,"usd":0.03878,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8794,"output_tokens":3628,"usd":0.067335,"stage2_stop_reason":"end_turn"},"total_usd":0.106115,"stage1_batch_id":"msgbatch_01WokvBYTB6JLnYrpD4rXnyV","stage2_batch_id":"msgbatch_01M7hsQDvz6AqVC9DLVjQzzc","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"GRA17 is a Toxoplasma-secreted dense granule protein that localizes to the parasitophorous vacuole membrane (PVM) and mediates passive transport of small molecules across the PVM, functioning as a large non-selective pore. GRA17-deficient parasites exhibit aberrant PV morphology, reduced PVM permeability, structural instability, slow proliferation, and avirulence in mice. GRA17 functions synergistically with GRA23, and exogenous expression of GRA17 in Xenopus oocytes alters membrane conductance consistent with a large non-selective pore.\",\n      \"method\": \"Genetic knockout, PV permeability assays, complementation with Plasmodium EXP2, Xenopus oocyte electrophysiology, localization by fluorescence microscopy\",\n      \"journal\": \"Cell host & microbe\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (KO phenotype, electrophysiology, cross-species complementation, permeability assays, localization), replicated in subsequent studies\",\n      \"pmids\": [\"25974303\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GRA17 is functionally related to the Plasmodium EXP2 translocon protein and is conserved across PV-residing Apicomplexa. Complementation of GRA17-deficient Toxoplasma parasites with Plasmodium EXP2 rescues the GRA17-deficient phenotypes (PV morphology, permeability, growth), establishing functional conservation between these pore-forming proteins.\",\n      \"method\": \"Heterologous complementation of Toxoplasma GRA17 knockout with Plasmodium EXP2, PV morphology and permeability assays\",\n      \"journal\": \"Cell host & microbe\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean complementation experiment with functional readouts, replicated in follow-up studies\",\n      \"pmids\": [\"25974303\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GRA17 plays an important role in bradyzoite viability inside cysts. Deletion of GRA17 in the type II ME49 strain produced enlarged 'bubble vacuoles' with reduced PVM permeability. ME49Δgra17 parasites formed cysts in vitro at comparable rates to wild-type, but bradyzoite viability inside cysts was significantly reduced. Complementation with GRA17 expressed from a bradyzoite-specific promoter (SRS9) drastically increased bradyzoite viability, demonstrating GRA17's importance in the cyst stage.\",\n      \"method\": \"CRISPR-Cas9 knockout in ME49 strain, cyst formation assays, bradyzoite viability assays, genetic complementation with stage-specific promoters, PVM permeability assays\",\n      \"journal\": \"Frontiers in cellular and infection microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype, multiple complementation constructs, orthogonal readouts in single lab\",\n      \"pmids\": [\"31572690\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Deletion of gra17 in Toxoplasma gondii type II Pru strain abrogated acute infection and blocked cyst formation, demonstrating GRA17's role in establishing chronic infection. Pru:Δgra17 mutants developed PVs with abnormal morphology and exhibited a reduced growth rate compared to wild-type.\",\n      \"method\": \"CRISPR-Cas9 knockout, mouse infection model, PV morphology analysis, growth rate measurement\",\n      \"journal\": \"Parasitology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined phenotypic readouts, consistent with prior findings in RH and ME49, single lab\",\n      \"pmids\": [\"32686022\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In vivo CRISPR screen results suggest a role of GRA72 for normal GRA17/GRA23 localization, indicating that GRA72 is required upstream of GRA17 for its proper targeting to the PVM.\",\n      \"method\": \"In vivo CRISPR screen in C57BL/6 and Ifngr1-/- mice\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — screen result suggesting localization dependence, single method, no direct mechanistic follow-up in this paper\",\n      \"pmids\": [\"37269286\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GRA47 interacts with GRA72 (identified by immunoprecipitation), and both GRA47 and GRA72 are pore-forming proteins that regulate PVM permeability alongside GRA17. Overexpression of GRA17 (or GRA23 or GRA72) partially rescued aberrant PV morphology in Δgra47 parasites, and P. falciparum PfExp2 (an ortholog of GRA17/GRA23) fully rescued PV morphological defects in Δgra47, Δgra72, and Δgra17 strains, indicating partial functional redundancy among this family of pore-forming GRA proteins.\",\n      \"method\": \"Co-immunoprecipitation, gene deletion (CRISPR), PV morphology assays, overexpression complementation with GRA17/GRA23/GRA72 and PfExp2, electrophysiology (Xenopus oocytes)\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal IP, multiple KO strains, cross-species complementation, electrophysiology; published in peer-reviewed journal after preprint\",\n      \"pmids\": [\"38380952\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Co-immunoprecipitation demonstrated interaction of GRA47 with GRA72. Loss of GRA72 affected PV morphology, parasite growth, and infectivity. Overexpressing GRA17 partially rescued PVs with aberrant morphology in Δgra47 and Δgra72 parasites, while PfExp2 fully rescued the PV morphological defect in Δgra17, Δgra47, and Δgra72 strains.\",\n      \"method\": \"Co-immunoprecipitation, CRISPR knockout, overexpression complementation, PV morphology assays\",\n      \"journal\": \"International journal for parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and functional complementation, single lab, consistent with parallel study in mBio\",\n      \"pmids\": [\"38936501\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRA1 inactivation impaired the secretion of GRA17 to the PVM and disrupted the intravacuolar network (IVN), which mediates transport of molecules in and out of parasites. Mislocalization of GRA17 (and other GRA proteins) caused by GRA1 depletion resulted in a strong defect in absorbing nutrients (glucose, pantothenate) from host cells, placing GRA1 upstream of GRA17 in the nutrient uptake pathway.\",\n      \"method\": \"Conditional depletion of GRA1, fluorescence localization of GRA17, nutrient uptake assays, metabolic assays\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined localization and functional readouts, but GRA17 localization is a secondary finding in a paper focused on GRA1\",\n      \"pmids\": [\"40576341\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AAP7 (apical annuli protein 7) is required for efficient secretion of GRA17 from dense granules. AAP7 depletion causes reduced GRA17 secretion, leading to 'bubble' vacuoles characteristic of GRA17 loss. Overexpression of GRA17 overcomes AAP7 depletion and reduces bubble vacuoles, identifying reduced GRA17 secretion as the critical defect downstream of AAP7 loss.\",\n      \"method\": \"Conditional depletion (ATc-resistant stable line), GRA17 overexpression rescue, fluorescence microscopy of PV morphology\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — depletion with defined phenotype, rescue by GRA17 overexpression, but preprint and single lab\",\n      \"pmids\": [\"41256620\"],\n      \"is_preprint\": true,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Genetic ablation of TgGRA17 compromises the growth advantage conferred by elevated exogenous lactate, implicating GRA17 pore as the entry route for host-derived monocarboxylates (lactate, pyruvate) into the parasitophorous vacuole.\",\n      \"method\": \"Genetic knockout of GRA17 combined with hexokinase knockout, growth assays with elevated exogenous lactate\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined metabolic phenotype and specific substrate (monocarboxylates), but preprint and single lab\",\n      \"pmids\": [\"42124602\"],\n      \"is_preprint\": true,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"GRA17 is a Toxoplasma gondii dense granule protein that localizes to the parasitophorous vacuole membrane (PVM) and forms a large, non-selective passive pore (related to Plasmodium EXP2) that mediates small molecule permeability—including nutrient (glucose, monocarboxylates, pantothenate) uptake and metabolite efflux—across the PVM; its proper secretion to the PVM requires the intravacuolar network scaffold GRA1 and the apical annuli protein AAP7, it functions synergistically with the related pore-forming protein GRA23 (and partially with GRA47/GRA72), and its loss causes aberrant 'bubble vacuole' morphology, reduced PVM permeability, impaired tachyzoite proliferation, reduced bradyzoite viability in cysts, and parasite avirulence in mice.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRA17 is a Toxoplasma gondii dense granule protein that localizes to the parasitophorous vacuole membrane (PVM), where it forms a large non-selective pore mediating passive transport of small molecules across the PVM [#0]. This pore activity is functionally conserved with the Plasmodium EXP2 translocon, which fully complements GRA17-deficient parasites for PVM permeability, PV morphology, and growth [#0, #1]. GRA17 operates within a redundant family of pore-forming GRA proteins, acting synergistically with GRA23 and partially interchangeably with GRA47 and GRA72, whose overexpression partially rescues aberrant PV morphology in reciprocal deletion mutants [#0, #5]. Functionally, the GRA17 pore serves as an entry route for host-derived nutrients including glucose, pantothenate, and monocarboxylates such as lactate and pyruvate into the vacuole [#7, #9]. Proper delivery of GRA17 to the PVM depends on the intravacuolar network scaffold GRA1 and on the apical annuli protein AAP7, both of which act upstream of GRA17 secretion [#7, #8]. Loss of GRA17 produces enlarged 'bubble' vacuoles with reduced PVM permeability, structural instability, slow proliferation, avirulence in mice, and impaired chronic infection—including reduced bradyzoite viability within cysts and blocked cyst formation [#0, #2, #3].\",\n  \"teleology\": [\n    {\n      \"year\": 2015,\n      \"claim\": \"Established that GRA17 is the molecular basis of passive small-molecule permeability across the PVM, answering how the intracellular parasite exchanges solutes with the host cytosol.\",\n      \"evidence\": \"Genetic knockout with PVM permeability assays, Xenopus oocyte electrophysiology, and cross-species complementation with Plasmodium EXP2 in RH strain\",\n      \"pmids\": [\"25974303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pore selectivity and structural architecture not resolved\", \"Full spectrum of transported solutes not defined\", \"Mechanism of synergy with GRA23 not characterized\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that GRA17 pore function is evolutionarily conserved across PV-residing Apicomplexa by showing Plasmodium EXP2 fully rescues GRA17 loss, unifying these pore-forming proteins mechanistically.\",\n      \"evidence\": \"Heterologous complementation of Toxoplasma GRA17 knockout with Plasmodium EXP2 and functional readouts in RH strain\",\n      \"pmids\": [\"25974303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural equivalence of the two pores not established\", \"Whether native cofactors differ between species unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended GRA17's role beyond acute infection by showing it is required for bradyzoite viability within cysts, linking PVM permeability to persistence of the chronic stage.\",\n      \"evidence\": \"CRISPR-Cas9 knockout in ME49 strain with cyst formation and bradyzoite viability assays and stage-specific promoter complementation\",\n      \"pmids\": [\"31572690\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific metabolic requirement of bradyzoites met by GRA17 not identified\", \"Whether cyst wall permeability compensates in vivo unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Confirmed GRA17's requirement for establishing chronic infection by showing deletion abrogates acute infection and blocks cyst formation in a type II strain.\",\n      \"evidence\": \"CRISPR-Cas9 knockout with mouse infection model and PV morphology analysis in Pru strain\",\n      \"pmids\": [\"32686022\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular cause of block in cyst formation not defined\", \"Contribution of host immune context not dissected\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"Pru\"}]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a redundant family of pore-forming GRA proteins by showing GRA47/GRA72 regulate PVM permeability alongside GRA17 and that cross-family and cross-species overexpression rescues morphological defects, clarifying functional interchangeability.\",\n      \"evidence\": \"Co-immunoprecipitation, multiple CRISPR knockouts, overexpression and PfExp2 complementation, and Xenopus oocyte electrophysiology in RH strain\",\n      \"pmids\": [\"38380952\", \"38936501\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether these proteins form a shared complex or independent pores unresolved\", \"Stoichiometry and assembly of the family not determined\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Placed GRA1 upstream of GRA17 by showing that GRA1 loss mislocalizes GRA17 and impairs nutrient (glucose, pantothenate) uptake, connecting IVN scaffolding to pore delivery.\",\n      \"evidence\": \"Conditional depletion of GRA1 with GRA17 localization, nutrient uptake and metabolic assays in RH strain\",\n      \"pmids\": [\"40576341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GRA1 directly traffics GRA17 or acts indirectly via IVN not distinguished\", \"GRA17 localization was a secondary finding in a GRA1-focused study\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified AAP7 as a secretion factor for GRA17 by showing AAP7 depletion reduces GRA17 secretion and produces bubble vacuoles that GRA17 overexpression reverses, pinpointing GRA17 delivery as the critical downstream defect.\",\n      \"evidence\": \"Conditional depletion with GRA17 overexpression rescue and PV morphology microscopy in RH strain (preprint)\",\n      \"pmids\": [\"41256620\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, single lab\", \"Mechanism by which apical annuli protein controls dense granule secretion unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Assigned monocarboxylates (lactate, pyruvate) as substrates transported by the GRA17 pore by showing GRA17 ablation removes the growth advantage of exogenous lactate, refining the nutrient-uptake role.\",\n      \"evidence\": \"GRA17 knockout combined with hexokinase knockout and growth assays under elevated exogenous lactate (preprint)\",\n      \"pmids\": [\"42124602\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, single lab\", \"Direct transport measurement of monocarboxylates through GRA17 not shown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural architecture of the GRA17 pore, its selectivity determinants, and whether the GRA17/GRA23/GRA47/GRA72 family assembles into a shared translocon complex remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the pore\", \"Assembly and stoichiometry of the pore-forming GRA family undefined\", \"Direct biochemical demonstration of individual solute transport lacking\"],\n      \"attribution\": []\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0022829\", \"supporting_discovery_ids\": [0, 1, 5], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]},\n      {\"term_id\": \"GO:0015144\", \"supporting_discovery_ids\": [7], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]},\n      {\"term_id\": \"GO:0008028\", \"supporting_discovery_ids\": [9], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020005\", \"supporting_discovery_ids\": [0, 7, 8], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]},\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [0], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0015850\", \"supporting_discovery_ids\": [7, 9], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]},\n      {\"term_id\": \"GO:0006810\", \"supporting_discovery_ids\": [0], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GRA23\", \"GRA47\", \"GRA72\", \"GRA1\", \"AAP7\"],\n    \"other_free_text\": [\n      \"Forms a large non-selective passive pore in the PVM functionally interchangeable with Plasmodium EXP2 [#0, #1, #5].\",\n      \"Loss produces enlarged 'bubble' vacuoles with reduced PVM permeability and structural instability [#0, #2, #8].\",\n      \"Required for tachyzoite proliferation, virulence in mice, and chronic infection including bradyzoite viability in cysts [#0, #2, #3].\",\n      \"Secretion to the PVM depends on GRA1 and AAP7 acting upstream [#7, #8].\"\n    ]\n  },\n  \"strain_conflicts\": []\n}","audit_flag":null,"strains":[{"strain":"ME49","gene_id":"TGME49_222170","name":"GRA17","product":"dense granule protein GRA17","uniprot_acc":"S8GTZ8","chromosome":"TGME49_chrII","start_pos":928666},{"strain":"GT1","gene_id":"TGGT1_222170","name":null,"product":"dense-granule antigen DG32","uniprot_acc":null,"chromosome":"TGGT1_chrII","start_pos":911318},{"strain":"RH88","gene_id":"TGRH88_001190","name":null,"product":"dense-granule antigen DG32","uniprot_acc":null,"chromosome":"CM023083","start_pos":1084458},{"strain":"VEG","gene_id":"TGVEG_222170","name":null,"product":"dense-granule antigen DG32","uniprot_acc":"B9PYT2","chromosome":"TGVEG_chrII","start_pos":932115}]}